12:28 PM ET
Earnings Call
▶ Call
Royalty Pharma Earnings Call: Key Takeaways
Royalty Pharma raised 2026 guidance for the third consecutive quarter, driven by 12% year-to-date royalty receipt growth and strong clinical success across its development-stage portfolio.
- Call
- Nov 4, 2026, 8:00 AM ET